These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32579819)

  • 1. Choosing Anticonvulsant Medications to Manage Status Epilepticus.
    Wu K; Hirsch LJ; Babl FE; Josephson SA
    N Engl J Med; 2020 Jun; 382(26):2569-2572. PubMed ID: 32579819
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus.
    Kapur J; Elm J; Chamberlain JM; Barsan W; Cloyd J; Lowenstein D; Shinnar S; Conwit R; Meinzer C; Cock H; Fountain N; Connor JT; Silbergleit R;
    N Engl J Med; 2019 Nov; 381(22):2103-2113. PubMed ID: 31774955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of generalised convulsive status epilepticus (SE): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam--Pilot study.
    Mundlamuri RC; Sinha S; Subbakrishna DK; Prathyusha PV; Nagappa M; Bindu PS; Taly AB; Umamaheswara Rao GS; Satishchandra P
    Epilepsy Res; 2015 Aug; 114():52-8. PubMed ID: 26088885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Phenytoin, Valproate and Levetiracetam in Pediatric Convulsive Status Epilepticus: A Randomized Double-blind Controlled Clinical Trial.
    Vignesh V; Rameshkumar R; Mahadevan S
    Indian Pediatr; 2020 Mar; 57(3):222-227. PubMed ID: 32198861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the relative value of the standard anticonvulsants: Phenytoin and fosphenytoin, phenobarbital, valproate, and levetiracetam?
    Trinka E
    Epilepsia; 2009 Dec; 50 Suppl 12():40-3. PubMed ID: 19941522
    [No Abstract]   [Full Text] [Related]  

  • 6. Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam.
    Alvarez V; Januel JM; Burnand B; Rossetti AO
    Epilepsia; 2011 Jul; 52(7):1292-6. PubMed ID: 21480881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam compared with phenytoin or fosphenytoin in benzodiazepine-refractory pediatric status epilepticus.
    Long B; Gottlieb M
    Acad Emerg Med; 2022 Jan; 29(1):125-127. PubMed ID: 33999500
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenytoin and levetiracetam are equally effective second-line treatments for status epilepticus.
    Dalrymple RA
    Arch Dis Child Educ Pract Ed; 2020 Oct; 105(5):319-320. PubMed ID: 31826874
    [No Abstract]   [Full Text] [Related]  

  • 9. Status epilepticus: clinical analysis of a treatment protocol based on midazolam and phenytoin.
    Brevoord JC; Joosten KF; Arts WF; van Rooij RW; de Hoog M
    J Child Neurol; 2005 Jun; 20(6):476-81. PubMed ID: 15996395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of status epilepticus: an international survey of experts.
    Riviello JJ; Claassen J; LaRoche SM; Sperling MR; Alldredge B; Bleck TP; Glauser T; Shutter L; Treiman DM; Vespa PM; Bell R; Brophy GM;
    Neurocrit Care; 2013 Apr; 18(2):193-200. PubMed ID: 23097138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam for convulsive status epilepticus in childhood: systematic review and meta-analysis.
    Abdelgadir I; Hamud A; Kadri A; Akram S; Pullattayil A; Akobeng AK; Powell C
    Arch Dis Child; 2021 Apr; 106(5):470-476. PubMed ID: 33060105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs for epilepsy.
    Med Lett Drugs Ther; 1986 Sep; 28(723):91-4. PubMed ID: 3091998
    [No Abstract]   [Full Text] [Related]  

  • 13. Drugs for epilepsy.
    Med Lett Drugs Ther; 1983 Sep; 25(643):81-4. PubMed ID: 6412042
    [No Abstract]   [Full Text] [Related]  

  • 14. Generalized convulsive status epilepticus: causes, therapy, and outcome in 346 patients.
    Scholtes FB; Renier WO; Meinardi H
    Epilepsia; 1994; 35(5):1104-12. PubMed ID: 7925159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exceptionally long absence status: multifactorial etiology, drug interactions and complications.
    D'Agostino MD; Andermann F; Dubeau F; Fedi M; Bastos A
    Epileptic Disord; 1999 Dec; 1(4):229-32. PubMed ID: 10937158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric status epilepticus: improved management with new drug therapies?
    Verrotti A; Ambrosi M; Pavone P; Striano P
    Expert Opin Pharmacother; 2017 Jun; 18(8):789-798. PubMed ID: 28481700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current state of treatment of status epilepticus.
    Hirsch LJ; Claassen J
    Curr Neurol Neurosci Rep; 2002 Jul; 2(4):345-56. PubMed ID: 12044254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory idiopathic absence status epilepticus: A probable paradoxical effect of phenytoin and carbamazepine.
    Osorio I; Reed RC; Peltzer JN
    Epilepsia; 2000 Jul; 41(7):887-94. PubMed ID: 10897162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status epilepticus in pregnancy: a literature review and a protocol proposal.
    Roberti R; Rocca M; Iannone LF; Gasparini S; Pascarella A; Neri S; Cianci V; Bilo L; Russo E; Quaresima P; Aguglia U; Di Carlo C; Ferlazzo E
    Expert Rev Neurother; 2022 Apr; 22(4):301-312. PubMed ID: 35317697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Toxin-Related Status Epilepticus With Levetiracetam, Fosphenytoin, or Valproate in Patients Enrolled in the Established Status Epilepticus Treatment Trial.
    Coralic Z; Kapur J; Olson KR; Chamberlain JM; Overbeek D; Silbergleit R
    Ann Emerg Med; 2022 Sep; 80(3):194-202. PubMed ID: 35718575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.